Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: How specific is specific?

Clinical Chemistry

Volumn 45, Issue 3, 1999, Pages 371-381

  Steimer, Werner ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DRUG METABOLITE; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY;

EID: 0032963830     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.3.371     Document Type: Article

References (60)

1. 1. Yatscoff RW, Rosano TG, Bowers LD. The clinical significance of cyclosporin metabolites. Clin Biochem 1991;24:23-35.
2. 2. Christians U, Sewing KF. Cyclosporin metabolism in transplant patients. Pharmacol Ther 1993;57:291-345.
3. 3. Kahan BD, Shaw LM, Holt D, Grevel J, Johnston A. Consensus Document: Hawks Cay meeting on therapeutic drug monitoring of cyclosporine. Clin Chem 1990;36:1510-6.
4. 4. Shaw LM, Yatscoff RW, Bowers LD, Freeman DJ, Jeffery JR, Keown PA, et al. Canadian consensus meeting on cyclosporine monitoring: report of the consensus panel. Clin Chem 1990; 36:1841-6.
5. 5. Morris RG, Tett SE, Ray JE. Cyclosporin A monitoring in Australia: consensus recommendations. Ther Drug Monit 1994;16:570-6.
6. 6. Oellerich M, Armstrong VW, Kahan B, Shaw L, Holt DW, Yatscoff R, et al. Lake Louise consensus conference on cyclosporin monitoring in organ transplantation: report of the consensus panel. Ther Drug Monit 1995;17:642-54.
7. 7. Pfeiffer M, Leaver N, Ali R, Cremer P, Fraunberger P, Lohse P, et al. Syva Emit® cyclosporin assay - a novel whole blood pretreatment reagent [Abstract]. Clin Chem 1996;42:S227.
8. 8. Steimer W. Evaluation of the AxSYM CsA assay compared with HPLC, TDx monoclonal and Emit with both pretreatments. Transplant Proc 1998;30: 4045-7.
9. 9. Schumann G, Petersen D, Hoyer PF, Wonigeit K. Monitoring cyclosporin A (ciclosporin, INN) concentrations in whole blood: evaluation of the Emit assay in comparison with HPLC and RIA. Eur J Clin Chem Clin Biochem 1993;31:381-8.
10. 10. Winkler M, Schumann G, Petersen D, Oellerich M, Wonigeit K. Monoclonal fluorescence polarization immunoassay evaluated for monitoring cyclosporine in whole blood after kidney, heart, and liver transplantation. Clin Chem 1992;38:123-6.
11. 11. McBride JH, Kim SS, Rodgerson DO, Reyes AF, Ota MK. Measurement of cyclosporine by liquid chromatography and three immunoassays in blood from liver, cardiac, and renal transplant recipients. Clin Chem 1992;38:2300-6.
12. 12. Armijo JA, Navarro FA, Angeles de Cos M. Is the monoclonal fluorescence polarization immunoassay for cyclosporine specific? Comparison with specific radioimmunoassay. Ther Drug Monit 1992;14:333-8.
13. 13. Dasgupta A, Saldana S, Desai M. Analytical performance of Emit™ cyclosporine assay evaluated [Abstract]. Clin Chem 1991; 37:2130-3.
14. 14. Melchior A, Krueger Nelson S, Raisys VA, Toivola B. Comparison of HPLC, RIA and Emit for routine monitoring of cyclosporine in whole blood [Abstract]. Clin Chem 1991;37:991.
15. 15. Moyer TP, Winkels J, Krom R, Wiesner R .Evaluation of Abbott TDx monoclonal assay of cyclosporine in whole blood. Clin Chem 1991;37:1120-1.
16. 16. Rogers LC, Smith FA, Jamero A. Evaluation of the Abbott TDx monoclonal cyclosporine A assay in pediatric cardiac transplant patients [Abstract]. Clin Chem 1991;37:1014.
17. 17. Rosano T, Brooks C III, Dybas M. Emit monoclonal antibody assay evaluated for cyclosporine monitoring in whole blood [Abstract]. Clin Chem 1991;37:989.
18. 18. Schroeder T, Vine W, Ruckrigl D, Pesce A, Bath G, First R. Evaluation of the new cyclosporine monoclonal antibody fluorescent polarization immunoassay in cardiac and renal transplants [Abstract]. Clin Chem 1991;37:990.
19. 19. Wang PP, Simpson E, Meucci V, Morrison M, Lunetta S, Zajac M, Boeckx R. Cyclosporine monitoring by fluorescence polarization immunoassay. Clin Biochem 1991;24:55-8.
20. 20. Yatscoff RW, Copeland KR, Faraci CJ. Abbott TDx monoclonal antibody assay evaluated for measuring cyclosporine in whole blood. Clin Chem 1990;36:1969-73.
21. 21. Kyne F, Maguire S, O'Broin S, McGing P, MCCann S, Wright E. Abbott TDx "selective" assay overestimates cyclosporine in whole blood. Clin Chem 1991;37:1657-8.
22. 22. Taylor PJ, Salm P, Norris RL, Ravenscroft PJ, Pond SM. Comparison of high-performance liquid chromatography and monoclonal fluorescence polarization immunoassay for the determination of whole-blood cyclosporin A in liver and heart transplant patients. Ther Drug Monit 1994;16:526-30.
23. 23. Lensmeyer GL, Wiebe DA, Carlson IH, deVos DJ. Three commercial polyclonal immunoassays for cyclosporine in whole blood compared. 2. Cross-reactivity of the antisera with cyclosporine metabolites. Clin Chem 1990;36:119-23.
24. 24. Wallemacq PE, Lee SC, Lho ST, Hassoun A. Cross-reactivity of cyclosporine metabolites in two different radioimmunoassays in which the same specific monoclonal antibody is used. Clin Chem 1990;36:385.
25. 25. Bowers LD. Cyclosporine analysis by high-performance liquid chromatography: precision, accuracy, and minimum detectable quantity. Transplant Proc 1990;22:1150-4.
26. 26. Witzke O, Heemann U, Thesing A, Wolfhard U, Erhard J, Philipp T, Michel MC. A comparison of Emit and FPIA methods for the detection of cyclosporin A blood levels: does impaired liver function make a difference? Eur J Clin Pharmacol 1997;52:413-6.
27. 27. Holt DW, Johnston A, Marsden JT, Vernillet L, Keown PA, Rosano TG, et al. Monoclonal antibodies for radioimmunoassay of cyclosporine: a multicenter comparison of their performance with the Sandoz polyclonal radioimmunoassay kit. Clin Chem 1988;34: 1091-6.
28. 28. Wang CP, Burckart GJ, Ptachcinski RJ, Venkataramanan R, Schwinghammer T, Hakala T, et al. Cyclosporine metabolite concentrations in the blood of liver, heart, kidney, and bone marrow transplant patients. Transplant Proc 1988;20(Suppl 2): 591-6.
29. 29. Lindholm A, Henricsson S. Simultaneous monitoring of cyclosporin in blood and plasma with four analytical methods: a clinical evaluation. Transplant Proc 1989;21:1472-4.
30. 30. Holt DW, Marsden JT, Fashola TO, Johnston A. Performance of the Sandoz radioimmunoassays for cyclosporine. Transplant Proc 1990;22:1155-9.
31. 31. Bowers LD. Therapeutic monitoring for cyclosporine: difficulties in establishing a therapeutic window. Clin Biochem 1991;24:81-7.
32. 32. Lensmeyer GL, Wiebe DA, Carlson IH. Deposition of nine metabolites of cyclosporine in human tissues, bile, urine, and whole blood. Transplant Proc 1988;20:614-22.
33. 33. Bleck JS, Schlitt HJ, Christians U, Schottmann R, Thiesemann C, Strohmeyer S, et al. Ciclosporin metabolite pattern in blood and urine of kidney graft patients in relation to liver function. Eur J Clin Pharmacol 1991;40:565-9.
34. 34. Vine W, Bowers LD. Cyclosporine: structure, pharmacokinetics, and therapeutic drug monitoring. Crit Rev Clin Lab Sci 1987;25: 275-311.
35. 35. Hesse CJ, Baan CC, Daane R, Stolk BJ, Jutte NH, Hendriks GF, Weimar W. Comparison of four different cyclosporine immunoassays in heart and kidney transplant recipients. Ther Drug Monit 1990;12:547-53.
36. 36. Wonigeit K, Kohlhaw K, Winkler M, Schaefer O, Pichlmayr R. Cyclosporine monitoring in liver allograft recipients: two distinct patterns of blood level derangement associated with nephrotoxicity. Transplant Proc 1990;22:1305-11.
37. 37. Lindholm A, Dahlqvist R, Groth GG, Sjoqvist F. A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation. Br J Clin Pharmacol 1990;30:443-52.
38. 38. Vine W, Bowers LD. Cyclosporine: assay by HPLC and assay with monoclonal antibodies equivalent? [Letter]. Clin Chem 1988;34:998.
39. 39. Christians U, Kohlhaw K, Surig T, Bader A, Schottmann R, Linck A, et al. Parallel blood concentrations of second-generation cyclosporine metabolites and bilirubin in liver graft recipients. Ther Drug Monit 1995;17:487-98.
40. 40. Guengerich FP. Characterization of human microsomal cytochrome P-450 enzymes. Annu Rev Pharmacol Toxicol 1989;29: 241-64.
41. 41. Watkins PB. The cytochromes P-450. Gastroenterol Int 1990;3: 184-8.
42. 42. Tredger JM, Steward CM, Williams R. Cyclosporine blood levels - an evaluation of radioimmunoassay with selective monoclonal or polyclonal antibodies and high-performance liquid chromatography in liver transplant recipients. Transplantation 1988;46:681-6.
43. 43. Tredger JM, Gonde CE, Williams R. Monitoring cyclosporine in liver-transplant recipients: effects of clinical status on the performance of two monoclonal antibody-based methods. Clin Chem 1992;38:108-13.
44. 44. Blick KE, Melouk SH, Fry HD, Gillum RL. A validation study of selected methods routinely used for measurement of cyclosporine. Clin Chem 1990;36:670-4.
45. 45. Oldhafer KJ, Schumann G, Wonigeit K, Oellerich M, Ringe B, Pichlmayr R. Cyclosporine A monitoring by radioimmunoassay (RIA) and high-performance liquid chromatography (HPLC) after liver transplantation: influence of route of administration and of liver function on the RIA:HPLC ratio. Transplant Proc 1988;20:361-5.
46. 46. Lacerda MA, Bowers LD, Snover DC, Payne WD, Bloomer JR. Hepatic levels of cyclosporine and metabolites in patients after liver transplantation. Clin Transplant 1995;9:35-8.
47. 47. Brockmoller J, Neumayer HH, Wagner K, Weber W, Heinemeyer G, Kewitz H, Roots I. Pharmacokinetic interaction between cyclosporin and diltiazem. Eur J Clin Pharmacol 1990;38:237-42.
48. 48. Kunzendorf U, Walz G, Brockmoeller J, Neumayer HH, Jochimsen F, Roots I, et al. Effects of diltiazem upon metabolism and immunosuppressive action of cyclosporine in kidney graft recipients. Transplantation 1991;52:280-4.
49. 49. Yatscoff RW. Laboratory support for transplantation. Clin Chem 1994;40:2166-73.
50. 50. Bowers LD. Analytical goals in therapeutic drug monitoring. Clin Chem 1998;44:375-80.
51. 51. Holt DW, Johnston A. Cyclosporin A: analytical methodology and factors affecting therapeutic drug monitoring. Ther Drug Monit 1995;17:625-30.
52. 52. Kivisto KT. Misleading use of correlation and regression in method comparison studies of cyclosporine. Clin Chem 1993;39:167-8.
53. 53. Holt DW, Johnston A, Roberts NB, Tredger JM, Trull AK. Methodological and clinical aspects of cyclosporin monitoring: report of the Association of Clinical Biochemists task force. Ann Clin Biochem 1994;31:420-46.
54. 54. Nattermann U, Steimer W, Gokel JM, Seidel D, Land W. Clinical evaluation and therapeutic range of cyclosporine A as monitored by FPIA in kidney transplantation. Transplant Proc 1990;22: 1284-6.
55. 55. Steimer W, Nattermann U, Eber B, Seidel D, Land W. Postoperative CsA monitoring in kidney transplantation, comparison of three different assays. Second International Congress of Therapeutic Drug Monitoring and Toxicology, Barcelona [Abstract]. Quim Clin 1990:9:370.
56. 56. Chan GL, Weinstein SS, LeFor WW, Spoto E, Kahana L, Shires DL Relative performance of specific and nonspecific fluorescence polarization immunoassay for cyclosporine in transplant patients Ther Drug Monit 1992;14:42-7.
57. 57. Johnston A, Holt DW. Concentration-controlled trials. What does the future hold? Clin Pharmacokinet 1995;28:93-9.
58. 58. Aspeslet LJ, LeGatt DF, Murphy G, Yatscoff RW. Effect of assay methodology on pharmacokinetic differences between cyclosporine Neoral and Sandimmune formulations. Clin Chem 1997;43:104-8.
59. 59. Gonschior AK, Christians S, Winkler M, Linck A, Baumann J, Sewing KF. Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients. Clin Chem 1996;42:1426-32.
60. 60. Tredger JM, Gilkes CD, Gonde CE. Therapeutic monitoring of Tacrolimus (FK506) with the first-and second-generation microparticle enzyme immunoassays: performance and results in four patient populations. Ther Drug Monit 1998;20:266-75.